Radius is a biopharmaceutical company that focuses on developing cutting-edge therapeutics in the fields of oncology, endocrine diseases, and osteoporosis. Their research is underpinned by a rigorous scientific approach, and their goal is to bring new treatments to market that address important unmet needs. With a range of promising drug candidates in various stages of development, Radius is poised to play a significant role in shaping the future of these important medical fields.